Kadel, Jeannette
Bauer, Sebastian
Hermsen, Anke M.
Immisch, Ilka
Kay, Lara
Klein, Karl Martin
Knake, Susanne
Menzler, Katja
Reif, Philipp S.
Rosenow, Felix
Strzelczyk, Adam http://orcid.org/0000-0001-6288-9915
Article History
First Online: 17 July 2018
Compliance with ethical standards
:
: The study was supported by an unrestricted grant by Desitin Arzneimittel.
: J. Kadel, S. Bauer, A. M. Hermsen, I. Immisch, L. Kay, P. S. Reif report no conflicts of interest. K. M. Klein reports personal fees from UCB, Eisai, GW Pharmaceuticals and Novartis, outside the submitted work. S. Knake reports personal fees from Desitin, Eisai, UCB, as well as support for scientific meetings from AD-tech, Desitin, Eisai, GW Pharmaceuticals, LivaNova, Nihon Kohden and Novartis outside the submitted work. K. Menzler reports honoraria as advisory board member from Eisai and UCB, outside the submitted work. F. Rosenow reports personal fees from Eisai, grants and personal fees from UCB, grants and personal fees from Desitin Pharma, personal fees and other from Novartis, personal fees from Medronic, personal fees from Cerbomed, personal fees from ViroPharma and Shire, grants from European Union, grants from Deutsche Forschungsgemeinschaft, outside the submitted work. A. Strzelczyk reports personal fees and grants from Desitin Arzneimittel, Eisai, LivaNova, Sage Therapeutics, UCB Pharma and Zogenix, outside the submitted work. We confirm that we have read the Journal’s position on issues involved in ethical publication and affirm that this report is consistent with those guidelines.